Back
Seres Therapeutics Stock Predictions
Sponsored
MCRB
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
25
MCRB
Seres Therapeutics
Last Price:
0.58
Seasonality Move:
-13.92%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Seres Therapeutics Stock Forecast
-
Is Seres Therapeutics Stock Undervalued?
The current Seres Therapeutics [MCRB] share price is $0.59. The Score for MCRB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal. - MCRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Seres Therapeutics Stock Go Up Next Year?
Data Unavailable
Seres Therapeutics Stock Rating
Data Unavailable
Seres Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
serestherapeutics.com
52-Week Data
52-Week High:
2.05
52-Week Low:
0.54
Prediction Charts
Market Cap:
89.55M
Price in USD:
0.59
Volume:
5.38M
Beta:
2.03
Technical Analysis
SMA50:
0.86
SMA100:
0.93
SMA200:
0.92
52-Wk Change:
-44.84%
Stock Predictions
-
Is Seres Therapeutics stock public?
Yes, Seres Therapeutics is a publicly traded company. -
What is the Seres Therapeutics stock quote today?
The Seres Therapeutics stock price is 0.59 USD today. -
How to buy Seres Therapeutics stock online?
You can buy Seres Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-25 | 0.72 | 0.70 | 0.75 | 0.68 |
Oct-28 | 0.69 | 0.70 | 0.76 | 0.69 |
Oct-29 | 0.71 | 0.78 | 0.79 | 0.71 |
Oct-30 | 0.76 | 0.81 | 0.81 | 0.75 |
Oct-31 | 0.78 | 0.80 | 0.83 | 0.76 |
Nov-1 | 0.79 | 0.82 | 0.83 | 0.79 |
Nov-4 | 0.83 | 0.80 | 0.85 | 0.79 |
Nov-5 | 0.79 | 0.81 | 0.82 | 0.76 |
Nov-6 | 0.84 | 0.76 | 0.84 | 0.74 |
Nov-7 | 0.75 | 0.72 | 0.76 | 0.71 |
Nov-8 | 0.70 | 0.72 | 0.73 | 0.70 |
Nov-11 | 0.74 | 0.69 | 0.76 | 0.69 |
Nov-12 | 0.69 | 0.66 | 0.71 | 0.63 |
Nov-13 | 0.65 | 0.59 | 0.69 | 0.59 |
Seres Therapeutics Earnings
Data Unavailable
Seres Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.18 per share.
* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.